ResearcherCentral South UniversityNo recent work listed

Cong Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-6557-8409; OpenAlex author ID A5042189067. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper

Papers 1

ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer. Last author DOI 10.18632/aging.204324 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pian Yu · 1 shared paper, 2022 · strength 0.20
- Paper ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer. DOI 10.18632/aging.204324 ↗
Jie Li · 1 shared paper, 2022 · strength 0.20
- Paper ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer. DOI 10.18632/aging.204324 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.